Bruce L A Carter is Director of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of ENTA, which is worth approximately $0. The most recent transaction as insider was on Mar 21, 2022, when has been sold 6,000 shares (Common Stock) at a price of $68.03 per share, resulting in proceeds of $408,180. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

BRUCE L A CARTER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2022
SELL
Open market or private sale
$408,180 $68.03 p/Share
6,000 Reduced 100.0%
0 Common Stock
Mar 21 2022
BUY
Exercise of conversion of derivative security
$153,480 $25.58 p/Share
6,000 Added 50.0%
6,000 Common Stock

Also insider at

MRTX
Mirati Therapeutics, Inc. Healthcare
BLA

Bruce L A Carter

Director
San Diego, CA

Track Institutional and Insider Activities on ENTA

Follow ENANTA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTA shares.

Notify only if

Insider Trading

Get notified when an Enanta Pharmaceuticals Inc insider buys or sells ENTA shares.

Notify only if

News

Receive news related to ENANTA PHARMACEUTICALS INC

Track Activities on ENTA